Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134.1 USD | -1.86% | -4.11% | +1.45% |
09:50am | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Official Publications